1. Home
  2. VSTM vs OPY Comparison

VSTM vs OPY Comparison

Compare VSTM & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$7.89

Market Cap

723.8M

Sector

Health Care

ML Signal

HOLD

Logo Oppenheimer Holdings Inc. (DE)

OPY

Oppenheimer Holdings Inc. (DE)

HOLD

Current Price

$73.15

Market Cap

802.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTM
OPY
Founded
2010
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
723.8M
802.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VSTM
OPY
Price
$7.89
$73.15
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$13.38
N/A
AVG Volume (30 Days)
1.9M
46.2K
Earning Date
11-04-2025
01-30-2026
Dividend Yield
N/A
0.99%
EPS Growth
N/A
16.17
EPS
N/A
7.46
Revenue
$13,379,000.00
$1,453,063,000.00
Revenue This Year
$208.54
N/A
Revenue Next Year
$251.40
N/A
P/E Ratio
N/A
$9.77
Revenue Growth
33.79
13.48
52 Week Low
$4.01
$49.26
52 Week High
$11.25
$79.99

Technical Indicators

Market Signals
Indicator
VSTM
OPY
Relative Strength Index (RSI) 45.42 53.63
Support Level $6.68 $72.43
Resistance Level $8.88 $75.21
Average True Range (ATR) 0.55 2.02
MACD -0.02 -0.29
Stochastic Oscillator 54.09 32.54

Price Performance

Historical Comparison
VSTM
OPY

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

Share on Social Networks: